📰 James Helliwell News
James Helliwell News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from James Helliwell. Real-time updates on events, politics, business and more.
February 7, 2024
Following the release of new data, Raymond James analyst Rahul Sarugaser remains bullish about Eupraxia Pharmaceuticals
November 13, 2023
Placebo-controlled trial gives novel product a tentative boost
June 27, 2023
Raymond James analyst Rahul Sarugaser, who delivered on Monday a report where he reiterated a Strong Buy rating on Eupraxia Pharmaceuticals.
June 14, 2023
Eupraxia has received Fast Track designation from the US FDA for EP-104IAR to treat osteoarthritis of the knee in adult patients.
November 7, 2022
/CNW/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug...
September 27, 2022
The environmental aspect of the ESG strategies has overtaken the discussion in the sector, to the detriment of the social factor.
February 10, 2022
Retrofitting Shell’s Patricia Camila LNG tanker with air lubricationled to significant fuel and emissions savings for the giant vessel. Andrew Wade reports.